French National Registry of Rare Peritoneal Surface Malignancies (RENAPE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02834169 |
Recruitment Status : Unknown
Verified August 2017 by Hospices Civils de Lyon.
Recruitment status was: Active, not recruiting
First Posted : July 15, 2016
Last Update Posted : August 22, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.
In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.
All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
Condition or disease | Intervention/treatment |
---|---|
Rare Peritoneal Surface Malignancies Pseudomyxoma Peritonei Peritoneal Mesothelioma Desmoplastic Small Round Cell Tumor Psammocarcinoma Primary Peritoneal Serous Carcinoma Diffuse Peritoneal Leiomyomatosis Appendiceal Mucinous Neoplasms | Other: Non interventional |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 2171 participants |
Observational Model: | Cohort |
Time Perspective: | Other |
Target Follow-Up Duration: | 8 Years |
Official Title: | French National Registry of Rare Peritoneal Surface Malignancies (RENAPE Registry) |
Study Start Date : | October 2010 |
Estimated Primary Completion Date : | December 2018 |
Estimated Study Completion Date : | December 2018 |

Group/Cohort | Intervention/treatment |
---|---|
pseudomyxoma peritonei
Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
peritoneal mesothelioma
Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
desmoplastic small round cell tumor
Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
psammocarcinoma
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
primary peritoneal serous carcinoma
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
diffuse peritoneal leiomyomatosis
Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
appendiceal mucinous neoplasms
Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
|
Other: Non interventional
Data collection |
- Incidence of rare peritoneal surface malignancies [ Time Frame: year 5 ]Collect detailed clinical and histological diagnosis for estimating annual incidence rate
- Impact of specific treatment strategies [ Time Frame: year 5 ]Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.
Exclusion Criteria:
- Histological diagnostic of peritoneal surface malignancy not confirmed
- Expected clinical follow up data not available

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02834169

Principal Investigator: | François-Noël GILLY, Prof | Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, PIERRE-BENITE, FRANCE, 69495 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Hospices Civils de Lyon |
ClinicalTrials.gov Identifier: | NCT02834169 |
Other Study ID Numbers: |
69HCL16_0406 |
First Posted: | July 15, 2016 Key Record Dates |
Last Update Posted: | August 22, 2017 |
Last Verified: | August 2017 |
Rare peritoneal surface malignancies pseudomyxoma peritonei peritoneal mesothelioma desmoplastic small round cell tumor psammocarcinoma |
primary peritoneal serous carcinoma diffuse peritoneal leiomyomatosis appendiceal mucinous neoplasms registry population-based database |
Neoplasms Mesothelioma Mesothelioma, Malignant Cystadenocarcinoma, Serous Desmoplastic Small Round Cell Tumor Pseudomyxoma Peritonei Peritoneal Neoplasms Leiomyomatosis Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Adenoma Neoplasms, Mesothelial Lung Neoplasms Respiratory Tract Neoplasms |
Thoracic Neoplasms Neoplasms by Site Pleural Neoplasms Lung Diseases Respiratory Tract Diseases Cystadenocarcinoma Adenocarcinoma Neoplasms, Cystic, Mucinous, and Serous Sarcoma Neoplasms, Connective and Soft Tissue Adenocarcinoma, Mucinous Abdominal Neoplasms Digestive System Neoplasms Digestive System Diseases Peritoneal Diseases |